CLINICAL OUTCOMES AND DIAGNOSIS‐TO‐TREATMENT INTERVAL IN PATIENTS WITH NK/T‐CELL LYMPHOMA: 7‐YEAR FOLLOW‐UP OF THE NKEA STUDY. (12th June 2019) - Yamaguchi, M.; Suzuki, R.; Oguchi, M.; Miyazaki, K.; Taguchi, S.; Amaki, J.; Maeda, T.; Kubota, N.; Maruyama, D.; Terui, Y.; Sekiguchi, N.; Takizawa, J.; et al.